ShortageWatch

Methylprednisolone Acetate Injection shortage

Currently in Shortage

Methylprednisolone Acetate Injection is currently listed as Currently in Shortage in the FDA Drug Shortage Database. Reported reason: Demand increase for the drug.

Therapeutic category
Dosage form
Injection
Routes
INTRA-ARTICULAR, INTRALESIONAL, INTRAMUSCULAR, SOFT TISSUE
Last updated
04/08/2026

Strength variants

  • Not specified

Need sourcing help for Methylprednisolone Acetate Injection?

Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.

Connect with a sourcing partner

Manufacturers reporting shortage

Reason for shortage

Demand increase for the drug

Availability: Unavailable

ad slot 300x250

Related shortages in Rheumatology

This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.